Tag Archive
Breast cancer therapy reduces mastectomies (CancerFacts.com)
OKLAHOMA CITY, OK – Jan. 20, 2010 – A new treatment not only killed large cancer tumors, but reduced the need for mastectomies by almost 90 percent, say researchers at the University of Oklahoma. (read here…) Related items Breakthrough Breast Cancer Therapy Reduces Mastectomies; Saves Breast (redOrbit) Breakthrough breast cancer therapy reduces mastectomies, saves breast (Science Daily) Heat Treatment... »
Breakthrough Breast Cancer Therapy Reduces Mastectomies; Saves Breast (redOrbit)
Heat treatment with chemotherapy kills large tumors; Approved by FDA; Next stage clinical trials start this year at OUHSC OUHSC Public Affairs A new treatment developed and tested by University of Oklahoma researchers not only killed large cancer tumors, but reduced the need for mastectomies by almost 90 percent. (read here…) Related items Heat Treatment With Chemotherapy... »
Breakthrough breast cancer therapy reduces mastectomies, saves breast (Science Daily)
A new treatment not only killed large breast cancer tumors, but reduced the need for mastectomies by almost 90 percent. (read here…) Related items Breakthrough breast cancer therapy reduces mastectomies, saves breast (PhysOrg) Breast cancer therapy reduces mastectomies (CancerFacts.com) Heat Treatment With Chemotherapy Kills Large Tumors; Approved By FDA; Next Stage Clinical Trials Start This Year At … (Medical... »
Breakthrough breast cancer therapy reduces mastectomies, saves breast (PhysOrg)
A new treatment developed and tested by University of Oklahoma researchers not only killed large breast cancer tumors, but reduced the need for mastectomies by almost 90 percent. The latest results appear in an upcoming issue of the Annals of Surgical Oncology. (read here…) Related items Breakthrough breast cancer therapy reduces mastectomies, saves breast (Science Daily) Heat Treatment... »
Nanostart-Owned MagForce Nanotechnologies AG: Application Submitted For EU Regulatory Approval Of Nano-Cancer(R) Therapy (Medical News Today)
MagForce Nanotechnologies AG, the Berlin-based medical nanotechnology company majority owned by Nanostart AG, has submitted its application for the European regulatory approval of its Nano-Cancer® therapy. The application is based on the successful results of recent clinical trials involving patients with recurrent glioblastoma, an especially aggressive form of brain tumor… (read the story…) Related items MagForce Nanotechnologies... »
